MANGOCEUTICALS, INC. (MGRX)
↓ Download CSV- Sector Services
- Incorporated TX
- Fiscal year ends Dec 31
In fiscal 2025, MANGOCEUTICALS, INC. reported revenue of $456.0K, down 26.0% from the prior year. The company ran a net loss, with a net margin of -4526.8% and a gross margin of 54.9%. It held $16.09M in total assets against $890.6K in total liabilities.
Key ratios (FY2025)
54.9%
Gross margin
-3954.3%
Operating margin
-4526.8%
Net margin
-135.8%
Return on equity
-26.0%
Revenue growth (YoY)
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $456.0K | $615.9K | $731.5K | $8.9K | — |
| Cost of Revenue | $54.4K | $93.3K | $154.9K | $4.1K | — |
| Gross Profit | $250.4K | $380.0K | $431.5K | $4.8K | — |
| Operating Income | -$18.03M | -$7.97M | -$9.22M | -$1.99M | — |
| Net Income | -$20.64M | -$8.71M | -$9.21M | -$2.00M | — |
| EPS (Diluted) | $-2.17 | $-4.80 | $-8.58 | $-0.19 | — |
| Total Assets | $16.09M | $15.37M | $1.05M | $1.00M | — |
| Total Liabilities | $890.6K | $1.43M | $276.0K | $389.3K | — |
| Shareholders' Equity | $15.20M | $13.95M | $774.8K | $614.0K | -$16.7K |
| Cash & Equivalents | $1.49M | $58.7K | $739.0K | $682.9K | — |
| Operating Cash Flow | -$5.85M | -$4.86M | -$7.00M | -$1.35M | — |
| Capital Expenditures | — | — | $3.5K | $43.1K | — |
| Shares Outstanding | 15.89M | 3.25M | 1.43M | 13.37M | — |